Evidence map›Paper›PMID 35280420›Full record

ArticleAnnals of translational medicine2022

Chuancheng Gao, Fengjun Xiao, Lin Zhang, Yang Sun, Lei Wang, Xiang Liu, Huiyan Sun, Zhidan Xie, Yaqi Liang, Qinqin Xu and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. [SENP1 reduces ferroptosis of thyroid cancer cells by regulating hypoxia-inducible factor-1α].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Article
  4. Review
  5. Review
  6. Inducing ferroptosis to improve cancer therapy: a promising tool for enhancing immunotherapy.Journal of experimental & clinical cancer research : CR · 2025
    Review
  7. Article
  8. Naturally Derived SENP1 Inhibitors with Anticancer Activity.International journal of molecular sciences · 2025
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Chuancheng Gao *Laboratory of Molecular Diagnosis and Regenerative Medicine, Medical Research Center, the Affiliated Hospital of Qingdao University, Qingdao, China.
Fengjun Xiao *Beijing Institute of Radiation Medicine, Beijing, China.
Lin ZhangLaboratory of Molecular Diagnosis and Regenerative Medicine, Medical Research Center, the Affiliated Hospital of Qingdao University, Qingdao, China.
Yang SunLaboratory of Molecular Diagnosis and Regenerative Medicine, Medical Research Center, the Affiliated Hospital of Qingdao University, Qingdao, China.
Lei WangDepartment of Medical Oncology, Qinghai Provincial People's Hospital, Xining, China.
Xiang LiuDepartment of Emergency, Qinghai Provincial People's Hospital, Xining, China.
Huiyan SunMedical Research Institute, Hebei Yanda Hospital, Langfang, China.
Zhidan XieDepartment of Medical Oncology, School of Medicine, Qinghai University, Xining, China.
Yaqi LiangDepartment of Medical Oncology, School of Medicine, Qinghai University, Xining, China.
Qinqin XuDepartment of Medical Oncology, Qinghai Provincial People's Hospital, Xining, China.
Lisheng WangLaboratory of Molecular Diagnosis and Regenerative Medicine, Medical Research Center, the Affiliated Hospital of Qingdao University, Qingdao, China.
Beijing Radiation Center · CNQingdao University · CNQinghai Provincial Peoples Hospital · CNQinghai University · CNAffiliated Hospital of Qingdao University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ferroptosis is a type of cell death driven by iron accumulation and lipid peroxidation, which is involved in the pathogenesis of various tumors. Small ubiquitin-like modifier (SUMO)-specific protease 1 ( Methods: The gene expression of Results: Conclusions:

Indexed as

A20ferroptosisLung cancerSENP1target therapy

Identifiers

PMID35280420
PMCPMC8908163
OpenAlexW4214632473

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.